To clarify the molecular mechanism by which curcumin reverses paclitaxel resistance in HCC cells, we first evaluated the expression of Lin28B in paclitaxel treated, and curcumin and paclitaxel co-treated Hep3B/TAX cells. The gene discussed is LIN28B; the disease is hepatocellular carcinoma.